Moreover, high levels of circulating TGF‐beta were observed in Marfan mouse models and patients, suggesting it is an important factor involved in MFS.22, 23 Most of the treatment regimens adopted have been to antagonize TGF‐beta signalling with neutralizing antibodies or Losartan. This evidence concerns the gene TGFB1 and Marfan syndrome.